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A Moderate-Intensity Weight-Bearing
Exercise Program for a Person With
Type 2 Diabetes and Peripheral
Neuropathy
Lori J. Tuttle, Mary K. Hastings, Michael J. Mueller
Background and Purpose. The exercise guidelines for people with diabetes
mellitus and peripheral neuropathy (DMPN) have recently changed to allow
moderate-intensity weight-bearing exercise, but there are few reports in the literature
describing appropriate weight-bearing exercise for those with DMPN. This case
report describes a successful and safe progressive exercise program for an individual
with DMPN.
Case Description. The patient was a 76-year-old man with a 30-year history of
DMPN. He participated in a 12-week, moderate-intensity, progressive exercise
program (heart rate approximately 75% of maximum heart rate; rate of perceived
exertion11–13; 3 times per week) involving walking on a treadmill, balance exer-
cises, and strengthening exercises for the lower extremities using body weight
resistance.
Outcomes. Measurements were taken before and after the 12 weeks of exercise.
The patient’s Six-Minute Walk Test distance increased from 1,200 to 1,470 ft. His
Physical Performance Test score did not change. His Foot and Ankle Ability Measure
questionnaire score improved from 89 to 98. Dorsiflexor and plantar-flexor peak
torque increased (dorsiflexor peak torque: right side4.5–4.6 Nm, left side2.8–3.8
Nm; plantar-flexor peak torque: right side44.7–62.4 Nm, left side40.8–56.0
Nm), as did his average daily step count (6,176–8,273 steps/day). Close monitoring
of the plantar surface of the feet indicated that the exercise program was well
tolerated and there were no adverse events.
Discussion and Conclusions. This case report describes a moderate-intensity
exercise program that was successful in increasing some measures of muscle
strength, physical function, and activity without causing injury in an individual with
DMPN.
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Individuals with diabetes mellitusand peripheral neuropathy(DMPN) lack the critical level
of sensory feedback to protect their
feet from injury. Historically, their
inability to monitor their own skin
condition led the American Diabetes
Association (ADA) and the American
College of Sports Medicine (ACSM)
to recommend exercise that was
restricted to non–weight-bearing
activities (2006 guidelines).1 The
exercise guidelines have recently
changed, however, to allow individ-
uals with DMPN and without acute
ulceration to participate in moderate
weight-bearing exercise.2 Weight-
bearing exercise is important for this
population to help maintain mobil-
ity, bone health, and general fitness.
Although other non–weight-bearing
exercises may be beneficial, weight-
bearing exercise (walking in particu-
lar) does not require equipment or
access to a gym, which can be bar-
riers to continuing an exercise
program.
People with DMPN have lower-
extremity impairments, including
reduced ankle muscle strength and
volume.3–5 Evidence suggests that
the lower-extremity muscles in peo-
ple with DMPN have substantial
intermuscular adipose tissue (IMAT)
(the visible extracellular adipose tis-
sue that is located beneath the mus-
cle fascia and between and within
muscle groups6) and muscle atrophy
compared with their peers.7
These muscle changes likely contrib-
ute to the observed limitations in
physical mobility in people with
DMPN. Adults with DM have an
odds ratio of 2.0 for having mobility
limitations compared with those
without DM.8 The incidence of
impaired mobility increases with
peripheral artery disease or PN; indi-
viduals with DM and lower-
extremity diseases have an almost
3-fold increase in risk of impaired
mobility compared with those hav-
ing neither.8 An inability to walk a
quarter mile and inability to walk up
10 steps without resting are the most
frequently reported mobility limita-
tions.7 Little evidence exists to deter-
mine whether these impairments in
muscle strength and volume and in
mobility can improve with exercise.
The recent “Feet First” randomized
controlled clinical trial9 demon-
strated that people with DMPN
were able to participate in a low-
intensity walking program and show
a slight improvement in daily walk-
ing activity without increasing their
rate of ulceration. This finding led, in
part, to the change in exercise guide-
lines to allow people with DMPN
to participate in moderate-intensity
exercise. Despite the benefits of the
Feet First study, no lower-extremity
strength changes were observed in
the low-intensity, community-based
exercise program,10 and a Cochrane
review of the literature concluded
that there is inadequate evidence to
evaluate the effect of strengthening
exercise for people with DMPN.11
Because the intervention intensity
was quite low in the previous
reports, it is unclear whether people
with DMPN are able to increase
lower-extremity strength or reduce
mobility impairments with an appro-
priately prescribed moderate-intensity
exercise program. The Feet First
study helped to change the exercise
guidelines for people with DMPN
to allow more weight-bearing activ-
ity, but their exercise program did
not result in any changes in strength
or function. It remains unclear
whether a supervised, moderate-
intensity exercise program would
have improved results in changing
muscle strength and physical func-
tion in people with DMPN.
The purpose of this case report is to
describe the effects of a moderate-
intensity, 12-week, progressive walk-
ing and resistance exercise program
that reflects recently changed guide-
lines for exercise for people with
DMPN2 on physical performance
(Six-Minute Walk Test [6MWT],
Physical Performance Test [PPT],
and Foot and Ankle Ability Measure
[FAAM]), calf muscle performance
(dorsiflexor and plantar-flexor peak
torque), and calf muscle structure
and composition (IMAT, muscle




The case reported here is that of an
individual who participated in an
ongoing randomized controlled trial
comparing weight-bearing exercise,
non–weight-bearing exercise, and a
nonexercising condition for people
who have DMPN. The overall goal
of the trial is to determine whether
people with DMPN are able to
perform moderate-intensity weight-
bearing exercise to increase activity
level and physical mobility without
increasing the incidence of foot
ulcers or skin breakdown. This case
report is based on the patient’s
participation in the 12-week exer-
cise program as part of the clinical
trial. The patient provided written
informed consent, and the study was
approved by the Human Research
Protection Office at Washington Uni-
versity, St Louis, Missouri.
Patient
The patient was a 76-year-old Cauca-
sian man with a body mass index
(BMI) of 27.1 kg/m2 and a 30-year
history of type 2 diabetes mellitus.
He lived in the community and
reported independence in all of his
activities of daily living, although he
no longer drove. He also reported
that he avoids taking the stairs due to
a fear of falling. His comorbid condi-
tions included a history of myo-
cardial infarction, coronary artery
bypass graft, and hypertension that
was controlled with medication.
His blood sugar was controlled
through oral medication. His goals
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for the exercise program and physi-
cal therapy interventions included
improving his walking ability and
endurance and having an exercise
program that he could continue on
his own.
Clinical Impression 1
The patient did not have any medical
history that prohibited him from par-
ticipating in an exercise program,2
and his primary physician approved
his participation in the exercise pro-
gram. He ambulated independently
without an assistive device and had
been stable on his medications for
longer than 6 months. Based on this
clinical impression, we decided to
test his level of sensation, especially
on weight-bearing surfaces, to deter-
mine his risk of unperceived injury
during exercise activities. We also
wanted to take baseline measure-
ments of his muscle performance
and functional activities to help
determine the appropriate level of




The patient had severe peripheral
neuropathy based on his inability
to feel a 5.07 or 6.10 Semmes-
Weinstein monofilament on the plan-
tar surface of the foot and based on
his vibration perception threshold
of 50 V as measured with a biothesi-
ometer (threshold for neuropathy is
25 V; 50 V is the maximum value
of the machine).12,13 This level of
severe neuropathy placed him at risk
for unnoticed trauma, so we pro-
vided safety guidelines, as described
in the “Intervention” section.
Six-Minute Walk Test
The patient performed the 6MWT14
as a measure of physical function and
walking endurance, with a meaning-
ful change indicated by a change
in distance walked of greater than
72 ft (1 ft0.3048 m).15 The patient
walked back and forth in a hallway
between 2 cones that were placed
100 ft apart. He was told that the
goal was to walk as far as possible in
6 minutes. The 6MWT distance was
recorded as total distance walked in
feet. He was able to walk 1,200 ft in
his initial 6MWT.
Physical Performance Test
The modified 9-item PPT was used
to assess the patient’s physical func-
tion. This test is designed to mimic
activities of daily living and includes
items such as stair climbing and
the sit-to-stand maneuver. Scores on
the 9-item PPT have been shown to
correlate well with disability and
frailty.16 Each of the items is scored
on a scale of 0 to 4 based on the time
it takes to complete the task. Each
task is performed twice, and the
average time is used to determine
the score. The patient scored 29 on
his initial PPT. A maximum score is
36, and a minimum score is 0. Higher
scores indicate higher levels of phys-
ical function.
Foot and Ankle Ability Measure
The FAAM is a reliable, responsive,
and valid self-report measure of phys-
ical function for individuals with a
broad range of musculoskeletal dis-
orders of the lower leg, foot, and
ankle.17 The questions investigate
the individual’s perception of 26
activities of daily living (eg, walking
on even ground, walking up hills,
stepping up and down curbs, home
responsibilities, recreational activi-
ties). The FAAM was found to be
more responsive to changes in
functional status compared with the
36-Item Short-Form Health Survey
questionnaire (SF-36) and has a high
test-retest reliability value of .89, as
well as a minimal detectable change
of 5.7 points and a minimal clinically
important change of 8 points.17 A
higher score on the FAAM indicates
better physical function, with a max-
imum score of 100% and a minimum
score of 0%. This patient’s initial
FAAM score was 89%.
Ankle Dorsiflexor and
Plantar-Flexor Peak Torque
Concentric isokinetic ankle dorsi-
flexor and plantar-flexor peak torque
as measures of muscle performance
were assessed using a Biodex Multi-
joint System 3 Pro isokinetic dyna-
mometer (Biodex Medical Systems,
Shirley, New York). The tests were
performed at an angular velocity of
60°/s. The patient was allowed 3
practice trials to ensure he was com-
fortable with the tests. The mean val-
ues for peak torque were calculated
for 3 trials. The minimal detectable
change for ankle dorsiflexor and
plantar-flexor peak torque in older
adults is 0.12 Nm and 5.06 Nm,
respectively.18 The patient’s initial
plantar-flexor peak torque was 44.7
and 40.8 Nm for the right and
left sides, respectively, and his dorsi-
flexor peak torque was 4.5 and 2.8




Intermuscular adipose tissue and
lean muscle volumes were quantified
using magnetic resonance imaging
(MRI) on the right leg. The MRI scans
were performed with the patient in a
supine position with a Siemens CP
extremity coil placed over the right
calf muscle. The MRI measurements
were performed with a 3.0-tesla
magnet (Siemens Corp, New York,
New York) with a pulse sequence of
echo time12 milliseconds, repeti-
tion time1,500 milliseconds, and
matrix256  256; both a fat-
saturated image and a non-fat-
saturated image were collected.7
Thirty transverse slices were col-
lected beginning at the joint space
of the knee and proceeding distally.
The slices were 7 mm thick with
no interslice gap. Nine consecutive
slices were selected to calculate mus-
cle and IMAT volumes. Volumes
were quantified using a PC work-
station and custom-designed Matlab
software (MathWorks, Natick, Massa-
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chusetts). The software uses voxel
brightness to distinguish between
muscle and adipose tissues. The
subcutaneous adipose tissue was
removed from each image by draw-
ing a line along the deep fascial plane
surrounding the calf muscle so that
only the fat within and between the
muscles (IMAT) remained. The soft-
ware uses edge detection algorithms
to assist the user in separating the
subcutaneous fat from the muscle
as well as separating individual
muscles and muscle compartments.
The IMAT and muscle volumes are
reported in cubic centimeters. Based
on test-retest reliability of data
obtained for 21 subjects, the error
in measuring muscle volume is less
than 1% and less than 2% for measur-
ing fat volumes on average in any
muscle or compartment. The patient
initially had 48 cm3 of IMAT and 426
cm3 of lean muscle in the calf section
studied.
Activity Monitoring
The patient was given a StepWatch
activity monitor (Orthocare Innova-
tions, Oklahoma City, Oklahoma)
and was instructed to wear the mon-
itor around his ankle during all wak-
ing hours to determine baseline
activity levels. He was given the
monitor to wear for at least 9 con-
secutive days, calculating an average
of 7 days. The first and last days of
wear were deleted because a full
24 hours would not be recorded. For
a day to be included, the monitor
had to be worn for at least 8 hours.
After the initial baseline activity level
was determined, the patient contin-
ued to wear the activity monitor
for the duration of the study during
all waking hours. The device records
strides per day, and steps per day
were calculated by multiplying
strides by 2 (1 stride equals 2 steps).
Results of validity tests performed
in our laboratory indicate a mean
absolute error of 1.8% (SD2.4%) for
individuals with DMPN.12 Results
of the activity monitor were used to
prescribe the patient’s specific walk-
ing distance to start his progressive
walking program as described below
and to monitor his average daily step
count throughout the study. The
patient had an initial average daily
step count of 6,176 steps/day.
Clinical Impression 2
The patient was determined to be
appropriate for participation in this
exercise program due to the pres-
ence of DMPN and lack of any
severe foot deformities or comor-
bidities that might limit his ability to
tolerate 60 minutes of exercise. He
was chosen for this case report from
the initial group of study participants
due to his enthusiasm and adherence
to the exercise program, his severe
neuropathy with lack of severe
foot deformity, and his exemplary
participation and changes in out-
come measures during his 12-week
participation in the clinical trial.
Intervention
The patient participated in a
moderate-intensity weight-bearing
exercise program 3 times a week for
12 weeks. The exercises included in
this program were adapted from the
Feet First intervention9 and from
exercises used in prior interventions
that reduced falls in frail older adults
and those with peripheral neuropa-
thy.19 Where progression for an
activity was not described in the
published study, we added an appro-
priate exercise progression to maxi-
mize progressive improvements.
Activity performance was supervised
by a physical therapist. The exercise
sessions began with flexibility and
stretching exercises. The stretches
included: toe stretches aimed at
stretching the toe extensor muscles,
a supine hamstring muscle stretch,
prone knee flexion, rocking on
hands and knees, and a standing calf
stretch. Each stretch was performed
twice with a 30-second hold. The
balance exercises followed a pro-
gressively challenging program in
which external support decreased
or the perturbation to a balanced
individual increased (eg, more com-
pliant surface, movement of arms
and legs). The strengthening exer-
cises were focused on the ankle
dorsiflexor and plantar-flexor mus-
cles using body-weight resistance
(ie, heel-raises, bilateral progressing
to unilateral for the plantar-flexor
muscles; stair climbing and sit-to-
stand maneuver for the hip, knee,
and ankle extensor muscles) rather
than machines or weights in an
effort to make the exercises easier to
continue after the end of the pro-
gram (Tab. 1).
The aerobic intervention included
walking on a treadmill for a duration
individually calculated for the patient
based on his own average step count
recorded over 7 days using the Step-
Watch activity monitor as described
above. The goal was for the patient
to increase his average step count
10% every 2 weeks by increasing his
daily step count 24% on the 3 days
that he participated in the exercise
program. In this case, he began with
a step count of 6,176 steps/day, and
the goal was to reach 10,712 steps/
day (see the Figure for step count
weekly goals). To reach the goal of
10,712 steps/day, the patient was
asked to walk 14 minutes on the
treadmill at each visit during the first
2 weeks with a goal of gaining an
additional 1,400 steps per exercise
visit during the time on the treadmill.
By maintaining his normal level of
activity when not exercising, his
average daily step count was
expected to increase by 10% over
the 2 weeks. The time on the tread-
mill was increased every 2 weeks to
continue to increase average daily
step count at a rate of 10% every 2
weeks. The patient wore a heart rate
monitor to assist the physical thera-
pist in ensuring that the exercise
intensity was within the mild to mod-
erate range based on heart rate
(40%–60% of maximum heart rate)
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and rate of perceived exertion of 11
to 13. Exercise participation was
modified, postponed, or stopped
based on guidelines established by
the ADA and ACSM.2 Exercise would
be postponed if: (1) blood glucose
level was greater than 300 mg/dL,
(2) resting systolic blood pressure
was greater than 200 mm Hg, or
(3) resting diastolic blood pressure
was greater than 110 mm Hg. If
blood glucose level was less than
80 to 100 mg/dL, carbohydrates
would be ingested. The entire exer-
cise program lasted approximately
60 minutes.
Precautions to Avoid Skin Injury
Before and after each exercise ses-
sion, the physical therapist and the
patient each performed a visual
inspection of the patient’s feet and
footwear. A digital photograph was
taken before and after the exercise
session to document the skin condi-
tion. Foot skin temperature was
recorded using a handheld infrared
thermometer (Diabetica Temptouch;
Diabetic Solutions Inc, San Antonio,
Texas) before and after each session
as described previously.20 The tem-
perature was recorded at 7 sites on
the plantar surface of the foot where
risk for skin breakdown is greatest:
the great toe; the first, third, and fifth
metatarsal heads; medial and lateral
midfoot; and the heel. The tempera-
ture measures were used to deter-
mine areas that might be at risk for
injury and were part of a composite
assessment for skin injury that
included redness, swelling, and pain.
If there was an area of redness, swell-
ing, pain, or increased temperature,
activity was limited, and the patient
was instructed to closely monitor the
area and decrease daily activity.
Adherence to Exercise
All exercise sessions were monitored
by a physical therapist. In order to
assist with transportation costs, the
patient received $10.00 for each
exercise visit he attended. The
patient attended 86% of the sched-
uled exercise classes. He missed 5
exercise sessions due to illness and
conflict with previously scheduled
physician’s appointments.
Table 1.
Exercises Performed During Weeks 1 and 12a
Week 1 Week 12
Toe crunches, 10 repetitions, 2 times Toe crunches, 35 repetitions, 2 times
Single-leg stand with one-hand support, 30 seconds, 2 times Single-leg stand with no hand support, 30 seconds, 2 times
Step sideways and step backward, 10 steps each, 2 times Step over 5 cones, 3 times
2-leg heel stands (toes up), 10 repetitions, 2 times 2-leg heel stands (toes up) 20 repetitions, 2 times
2-leg toe raises (heels up), 10 repetitions, 2 times Single-leg toe raises (heels up), 40 repetitions, 2 times
Sit-to-stand maneuver, 5 repetitions, 2 times Sit-to-stand maneuver, 20 repetitions, 2 times
Step ups with one-hand support, 10 repetitions, 2 times Climb 2 flights of stairs, 2 times
14-minute walk on treadmill, self-selected pace 24-minute walk on treadmill, self-selected pace
a Progression was determined at each exercise session based on the patient’s report of an exercise becoming easy and his tolerance for increasing his
repetitions of an exercise.
Figure.
Step activity monitor data by week. Patient’s actual average daily step count compared
with the target goal for average daily step count. Actual daily step count is represented
by circles, and average daily goal is represented by squares (goal was increased every
2 weeks). Note that average daily step count increased by 34%, but that the target goal
for average daily step count was not achieved.
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Outcomes
Data for outcome measures were
obtained before and after the
12-week moderate-intensity exercise
program (Tab. 2). The postinterven-
tion measurements were collected
within 72 hours of the final exercise
session. The patient was able to
progress on all of the prescribed
exercises and was able to increase
his time on the treadmill at his self-
selected pace of 2.0 mph from 14
minutes to 24 minutes. He was able
to tolerate a moderate-intensity exer-
cise program based on a measured
heart rate range of 80 to 109 bpm
during his treadmill walking (60%–
70% of his age-predicted maximum
heart rate is 86–101) and based on
a rate of perceived exertion of 11 to
13 on a 6 to 20 scale, which is con-
sistent with fairly light to moderate-
intensity exercise. The patient
improved his 6MWT distance from
1,200 to 1,470 ft. There was no
change in PPT score, but his FAAM
score improved from 89% to 98%.
The patient’s average daily step
count increased from 6,176 to 8,273
steps/day. His glucose control level
improved as indicated by a decrease
in glycosylated hemoglobin (HbA1c)
from 6.9% to 6.4%.
Dorsiflexor and plantar-flexor peak
torque increased (right dorsiflexor
peak torque4.5–4.6 Nm, left dor-
siflexor peak torque2.8–3.8 Nm,
right plantar-flexor peak torque
44.7–62.4 Nm, and left plantar-
flexor peak torque40.8–56.0 Nm).
Surprisingly, IMAT volume increased
(48–56 cm3) and calf muscle volume
decreased (426–390 cm3). He also
lost 5.9 kg (13 lb) over the 12-week
intervention.
The patient was able to tolerate the
12-week exercise program without
complications or skin breakdown.
His only injury came from trimming
his own toenails, and this injury
resolved in less than 1 week. We
monitored the patient’s blood glu-
cose level before and after each exer-
cise session, and he consistently had
blood glucose levels greater than
100 mg/dL and less than 300 mg/dL,
so no carbohydrates were ingested
before, during, or after exercise.
Based on temperature monitoring
on the plantar surface of the feet,
there were several instances where
the patient’s temperature difference
was greater than 4 degrees between
the right and left feet. Initially, we
instructed the patient to limit his
activity and did not allow him to
exercise on 2 occasions. Because
he continued to show temperatures
greater than 4 degrees between left
and right feet at the same location
and did not have negative conse-
quences, we changed our criteria to
include that there must be a temper-
ature difference of greater than 4
degrees as well as redness, swelling,
or pain in that area to require activity
limitation. The patient showed side-
to-side temperature differences 6
times but had no instances of skin
injury or skin breakdown after these
revised temperature guidelines were
in place.
Discussion
The guidelines from the ADA and
ACSM have recently changed to indi-
cate that people with DMPN
may participate in moderate weight-
bearing exercise. Prior to this
change in guidelines, it was recom-
mended that people with DMPN
limit weight-bearing activity due to
concerns about increased risk for
skin injury. This case report provides
an example of a moderate-intensity
weight-bearing exercise program
that was successful in safely increas-
ing 6MWT distance, average daily
step count, and ankle strength in a
person with DMPN.
The patient presented in this case
report was able to increase his
6MWT distance from 1,200 to 1,470
feet (22%) after the 12-week exercise
program. The 6MWT has been
shown to be a measure of overall
mobility and physical function,21,22
and a change of 270 ft is consistent
with a substantial change, as
reported by Perera et al.15 It seems
reasonable that the 6MWT distance
improved, as the patient participated
in a duration-based walking pro-
gram. Even though he did not
increase his walking speed during
treadmill training, he was able to
increase his walking speed during




6MWT distance (ft) 1,200 1,470
PPT score 29 30
FAAM score (%) 89 98
Self-report FAAM score (%) 98 100
Dorsiflexor peak torque (Nm), right/left 4.5/2.8 4.6/3.8
Plantar-flexor peak torque (Nm), right/left 44.7/40.8 62.4/56.0
Average daily step count 6,176 8,273
HbA1c (%) 6.9 6.4
IMAT volume (cm3) 48 56
Muscle volume (cm3) 426 390
Weight (lb) 178 165
a 6MWTSix-Minute Walk Test, PPTPhysical Performance Test, FAAMFoot and Ankle Ability
Measure, HbA1cglycosylated hemoglobin, IMATintermuscular adipose tissue.
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ing to walk, and he was successful in
improving his ability to walk.
In the case of this patient, PPT scores
did not change (29–30). However,
his FAAM score did improve by 9
points, which is beyond the minimal
detectable change (5.7 points) and
minimal clinically important change
(8 points) of the test.17 The patient
reported improvements on the
FAAM in walking uphill, climbing
stairs, going up and down curbs,
squatting, and doing heavy work (eg,
pushing and pulling, climbing, carry-
ing) and in recreational activities.
The FAAM is a measure of physical
function that is specific to activities
involving the foot, ankle, and lower-
extremity, whereas the PPT incorpo-
rates upper-extremity activities as
well. The exercise program reported
here is focused entirely on the lower
extremity, so it is possible that the
FAAM is a more sensitive measure
of improvement than the PPT in this
case. In addition, the FAAM is a self-
report measure, whereas the PPT is
a performance-based measure. It is
possible that this intervention did
not improve performance but may
have improved self-efficacy or what
this patient believes he is able to do.
Dorsiflexor and plantar-flexor
strength measures (peak torque)
responded differently from each
other in this intervention. The dorsi-
flexor peak torque values did not
change as much as the plantar-flexor
peak torque values, which increased
by 37% to 40% (0.1–1.0 Nm versus
15.2–17.7 Nm total change). There
are several reasons that could
account for this difference in
response. First, more of the exer-
cises in this program were focused
on increasing strength in the plantar
flexors. The primary exercise for
the dorsiflexors was heel stands
(toes up), whereas toe raises (heels
up), stair climbing, and the sit-to-
stand maneuver were performed
with the plantar flexors. It has been
reported previously that dorsiflexion
is impaired in people with DMPN.5
This patient’s preintervention plantar-
flexor peak torque values were
consistent with plantar-flexor peak
torque (right/left) values reported
for community-dwelling older adults
(44.7/40.8 Nm versus 37.7 Nm
reported), but his dorsiflexor peak
torque (right/left) values were lower
than those reported in the litera-
ture (4.5/2.8 Nm versus 9.5 Nm
reported).18 It is possible that due
to the process of diabetes mellitus
and peripheral neuropathy, the
dorsiflexors may be more difficult to
strengthen or less able to adapt than
the plantar flexors.
The Feet First study9 described a
low-intensity intervention for people
with DMPN aimed at increasing
walking activity and improving
strength, but the authors reported
no strength changes in their exercise
program. The intervention that we
describe here is more intensive than
the Feet First study, based on our
goal of increasing the step count by
10% every 2 weeks. This patient was
able to tolerate this more aggressive
program without injury or complica-
tions and was able to increase his
average daily step count from 6,176
to 8,273 steps/day (34% increase)
(Figure). However, he did not actu-
ally meet the target goal of increas-
ing his step count by 10% every 2
weeks (goal of 10,712 steps/day).
Because he was walking at his self-
selected pace and we based the
walking program on a predeter-
mined walking time, his actual steps
taken during the treadmill walk were
less than the number required for
the 10% increase to occur. During
weeks 10 to 12, there was a decline
in the patient’s average daily step
count (Figure). No exercise sessions
were missed during this time, but
the patient decreased his activity
outside of the exercise classes due
to high outside temperatures (heat
advisory warning people to stay
inside).
Although the patient was able to
increase his average daily activity,
ankle muscle strength, and 6MWT
distance, he lost weight overall and
he lost muscle volume and gained
IMAT in the calf. A previous study of
a walking program in older adults23
indicated that an exercise program
can attenuate strength loss and IMAT
gain in the thigh. Although a recent
study showed that lower levels of
physical activity are associated with
increased IMAT in the calf in people
with DMPN,24 it is unknown
whether neuropathic calf muscle is
able to adapt or what the intensity
of the stimulus should be to elicit
change in muscle structure. Based
on this case report, it appears that
changes in calf muscle volume and
calf IMAT volume are not directly
related to change in muscle perfor-
mance or physical function, but this
conclusion is in conflict with the
results of a previous study.7 Future
studies should focus on investigating
the relationship between IMAT and
muscle function and their response
to exercise.
This patient lost 5.9 kg during the
12 weeks of exercise interven-
tion, but there was no targeted
dietary intervention in the pro-
gram. It is unknown whether the
patient altered his diet in any way in
an effort to make healthy lifestyle
changes. We speculate that the mus-
cle loss in the calf was related to his
overall weight loss, but we were sur-
prised at the increase in the calf
IMAT volume and the magnitude of
the calf muscle loss. Better control
or information regarding diet and
its relationship to muscle changes
would be useful in future studies.
Although there was a decrease in
lean muscle volume of the calf in
this patient, this volume measure
was not capturing the entire calf
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muscle, so it is possible that there
were changes to the calf muscles
that occurred proximally or distally
to the region we captured in the
MRI. Future studies would benefit
from imaging the entire lower
extremity rather than a small region
of interest to determine any changes
to muscles with various neuropathic
involvements that occur from an
exercise program in this population.
Other investigators9 have indicated
that muscle quality (peak torque/
muscle volume) may be a key com-
ponent in muscle function. In this
case report, strength increased
despite a decrease in muscle volume,
which would indicate an improve-
ment in muscle quality as defined
by peak torque/muscle volume. It is
possible that the underlying contrac-
tile properties of the muscle were
changed, which could account for
the increase in peak torque indepen-
dent of a change in muscle volume.
It also is possible that the improve-
ment in muscle strength was due
to a change in the nervous system
rather than a change in the muscle
structure. We do not have measures
that answer these questions, but
they should be investigated in future
studies.
Of note, this patient’s HbA1c
dropped by 0.5% from 6.9% to 6.4%,
indicating an improvement in glu-
cose control over the 12 weeks of
exercise. Other exercise studies
have shown HbA1c reductions of
0.6% to 1.6% with combined aerobic
and resistance exercise programs of
8 weeks to 24 months.25–29 In all of
these studies, the exercise programs
were of higher intensity than the one
we report here, and further study
is needed to determine whether a
higher-intensity exercise program is
safe and can result in larger drops in
HbA1c in people with DMPN.
We can only speculate that even
with this moderate-intensity exercise
program, the muscles may have
improved insulin sensitivity, which
could have been responsible for
the improvement in HbA1c. More
research is needed to determine
whether this speculation is accurate.
Although this case report provides
important information for clinicians,
there are limitations to be consid-
ered. First, this is a case report of
a single patient, and it is unclear
whether these findings are generaliz-
able to the larger population with
DMPN. This person did not have
severe foot deformity or a history of
plantar ulcer, and studies are needed
to determine the safety of this type
of exercise for people with these
diabetic complications. We believe
that our precautions of a detailed
foot examination before and after
exercise are important components
of safe exercising by people with
DMPN. We also used temperature
measurements from the plantar sur-
face of the foot as a means of identi-
fying areas that might be at risk for
skin breakdown.20 However, there
were multiple false positives (cases
where the temperature difference
was greater than 4° between the
right and left feet without other signs
or symptoms indicating tissue dam-
age). For this patient, we concluded
that a detailed visual foot examina-
tion before and after exercise was
adequate to prevent injury. Addi-
tional research is needed to investi-
gate the usefulness of temperature
readings in populations at risk for
skin injury.
This case report provides an exam-
ple of a weight-bearing exercise pro-
gram that was successfully imple-
mented for a person with DMPN.
He was able to complete the pro-
gram without injury and increase his
6MWT distance, plantar-flexor peak
torque, and average daily step count.
More work is needed to determine
the appropriate intensity of exercise
to elicit changes in muscle structure
and to determine the safety of high-
intensity resistance and aerobic exer-
cise in people with DMPN.
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